NovaBay Pharmaceuticals, Inc.
For the period ended Jan 16, 2026. Filed Jan 16, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jan 16, 2026 · Filed Jan 16, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Other Recent Developments
Other Recent Developments
Effective January 1, 2026, we adopted Accounting Standards Update (“ASU”) No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets, which requires measurement of eligible crypto assets at fair value, with changes in fair value recognized in net income.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.